Bone marrow dose results in peptide receptor radionuclide therapy (PRRT) with Y-90-DOTA-Tyr3-Octreotide, In-111-DTPA-Octreotide and Lu-177-DOTA-Octreotate: Importance of dosimetry model.
JOURNAL OF NUCLEAR MEDICINE(2002)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要